Skip to main content
Top
Published in: Obesity Surgery 7/2008

01-07-2008 | Research Article

A Prospective Evaluation of a Variant of Biliopancreatic Diversion with Roux-en-Y Reconstruction in Mega-obese Patients (BMI ≥ 70 kg/m2)

Authors: Charalambos Spyropoulos, George Bakellas, George Skroubis, Ioannis Kehagias, Nancy Mead, Konstantinos Vagenas, Fotis Kalfarentzos

Published in: Obesity Surgery | Issue 7/2008

Login to get access

Abstract

Background

Super-obese patients with BMI ≥ 70 kg/m2 present a special subgroup among the obese population due to the higher incidence of severe comorbidities and increased technical difficulties in perioperative management. The optimal surgical approach still remains controversial.

Methods

From January 2002 to October 2007, 68 super-obese patients with BMI ≥ 70 kg/m2 (75.7 ± 5.61) and various comorbidities (mean 1.45 ± 1, range 0–5), underwent a variant of biliopancreatic diversion with Roux-en-Y reconstruction (BPD–RYGBP) at our institution. The mean age was 39.6 ± 9.5 years, and the excess weight was 146.1 ± 24.5 kg. The safety and the effectiveness of the procedure were prospectively evaluated.

Results

Thirty-one patients have completed their second postoperative year. Mean BMI after 2 years follow-up was 35 ± 5.33 kg/m2 (p < 0.001) and mean %EWL was 79.9% (range 57.17–149.89). Significant improvement in preexisting comorbidities was also observed (mean 0.95 ± 0.1, range 0–2; p < 0.001). Early major postoperative complications included one case of acute renal failure (1.47%), three anastomotic leaks (4.41%), four pulmonary embolisms (5.88%), one hemorrhage requiring reoperation (1.47%), and three cases of pneumonia (4.41%), resulting in a total morbidity rate of 8.82% and a mortality rate of 8.82%. Late complications included small bowel obstruction in four patients (5.88%), pulmonary embolism in one patient (1.47%), severe hypoalbuminemia requiring artificial nutrition support in six patients (8.82%), and incisional hernia in 23 patients (33.8%). Late morbidity was 41.1%, and there was no late mortality.

Conclusion

BPD-RYGBP appears to be an effective procedure in patients with BMI ≥ 70 kg/m2 providing adequate weight loss and improvement of co-existing comorbidies after 2 years. Nevertheless, it is associated with higher morbidity and mortality rates compared to patients with BMI < 70 kg/m2 undergoing the same surgical procedure.
Literature
1.
go back to reference Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.PubMed Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.PubMed
2.
go back to reference Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.PubMedCrossRef Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.PubMedCrossRef
3.
go back to reference Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002;6:195–203.PubMedCrossRef Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002;6:195–203.PubMedCrossRef
4.
go back to reference Fernandez AZ Jr, DeMaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698–702.PubMedCrossRef Fernandez AZ Jr, DeMaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698–702.PubMedCrossRef
5.
go back to reference Benotti PN, Wood GC, Rodriguez H, et al. Perioperative outcomes and risk factors in gastric surgery for morbid obesity: a 9-year experience. Surgery. 2006;139:340–6.PubMedCrossRef Benotti PN, Wood GC, Rodriguez H, et al. Perioperative outcomes and risk factors in gastric surgery for morbid obesity: a 9-year experience. Surgery. 2006;139:340–6.PubMedCrossRef
6.
go back to reference Raftopoulos I, Ercole J, Udekwu AO, et al. Outcomes of Roux-en-Y gastric bypass stratified by a body mass index of 70 kg/m2: a comparative analysis of 825 procedures. J Gastrointest Surg. 2005;9:44–52.PubMedCrossRef Raftopoulos I, Ercole J, Udekwu AO, et al. Outcomes of Roux-en-Y gastric bypass stratified by a body mass index of 70 kg/m2: a comparative analysis of 825 procedures. J Gastrointest Surg. 2005;9:44–52.PubMedCrossRef
7.
go back to reference Sarr MG, Felty CL, Hilmer DM, et al. Technical and practical considerations involved in operations on patients weighing more than 270 kg. Arch Surg. 1995;130:102–5.PubMed Sarr MG, Felty CL, Hilmer DM, et al. Technical and practical considerations involved in operations on patients weighing more than 270 kg. Arch Surg. 1995;130:102–5.PubMed
8.
go back to reference Kreitz K, Rovito PF. Laparoscopic Roux-en-Y gastric bypass in the “megaobese”. Arch Surg. 2003;138:707–9.PubMedCrossRef Kreitz K, Rovito PF. Laparoscopic Roux-en-Y gastric bypass in the “megaobese”. Arch Surg. 2003;138:707–9.PubMedCrossRef
9.
go back to reference Kalfarentzos F, Papadoulas S, Skroubis G, et al. Prospective evaluation of biliopancreatic diversion with Roux-en-Y gastric bypass in the super obese. J Gastrointest Surg. 2004;8:479–88.PubMedCrossRef Kalfarentzos F, Papadoulas S, Skroubis G, et al. Prospective evaluation of biliopancreatic diversion with Roux-en-Y gastric bypass in the super obese. J Gastrointest Surg. 2004;8:479–88.PubMedCrossRef
10.
go back to reference Bloomston M, Zervos EE, Camps MA, et al. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg. 1997;7:414–9.PubMedCrossRef Bloomston M, Zervos EE, Camps MA, et al. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg. 1997;7:414–9.PubMedCrossRef
11.
go back to reference DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.PubMedCrossRef DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.PubMedCrossRef
12.
go back to reference Demaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246:578–84.PubMedCrossRef Demaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246:578–84.PubMedCrossRef
13.
go back to reference Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan GSM, editors. Update: surgery for the morbidly obese patient. Toronto: FD Communications Inc. 2000:227–58. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan GSM, editors. Update: surgery for the morbidly obese patient. Toronto: FD Communications Inc. 2000:227–58.
14.
go back to reference Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.PubMedCrossRef Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.PubMedCrossRef
15.
go back to reference Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or = 50). Obes Surg. 2005;15:612–7.PubMedCrossRef Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or = 50). Obes Surg. 2005;15:612–7.PubMedCrossRef
16.
go back to reference Scopinaro N, Gianetta E, Friedman D, et al. Evolution of biliopancreatic bypass. Clin Nutr. 5(Suppl) 1986:137–46. Scopinaro N, Gianetta E, Friedman D, et al. Evolution of biliopancreatic bypass. Clin Nutr. 5(Suppl) 1986:137–46.
17.
go back to reference Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.PubMedCrossRef Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.PubMedCrossRef
18.
go back to reference Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.PubMedCrossRef Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.PubMedCrossRef
Metadata
Title
A Prospective Evaluation of a Variant of Biliopancreatic Diversion with Roux-en-Y Reconstruction in Mega-obese Patients (BMI ≥ 70 kg/m2)
Authors
Charalambos Spyropoulos
George Bakellas
George Skroubis
Ioannis Kehagias
Nancy Mead
Konstantinos Vagenas
Fotis Kalfarentzos
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 7/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9449-3

Other articles of this Issue 7/2008

Obesity Surgery 7/2008 Go to the issue